Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Annji, Artisan, Avenue, Beigene, Celltrion, Coya, Dr. Reddy’s, Genuv, Hutchmed, Leap, Prelude, Spybiotech, Summit Healthcare Acquisition, Takeda, Yishengbio, YS.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Advamedica, Brainomix, Etiometry, Graymatters Health, Inspire Medical Systems, Viz.ai.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Clario, Epic, Fluoguide, Guardant Health, Glaxosmithkline, Invitae, Oxford Nanopore, Pathoquest, Progentec, Strados.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Antengene, Aquavit, Arrowhead, Aviceda, Boan, Diamond, Enlivex, Fore, Ichnos, Intellia, Jiangsu Recbio, Luye, Mereo, Prestige, Sanofi, Sensei.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alexion, Astrazeneca, Beigene, Devshealth, Disc Enveric, Evofem, Ingenū, Lucy Scientific, Psyence, Quralis, Wesana, Zura.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allarity, Clairvoyant, Enlivex, Genentech, Kangpu, Karuna, Newron, Orsobio, Pharvaris, Rayzebio, Vaccitech, Vaxxinity, Xalud.